Adipocyte iron regulates adiponectin and insulin sensitivity

Journal of Clinical Investigation

Volumn 122, Issue 10, 2012, Pages 3529-3540

  Gabrielsen, J Scott ^a   Gao, Yan ^a   Simcox, Judith A ^a   Huang, Jingyu ^a   Thorup, David ^a   Jones, Deborah ^a   Cooksey, Robert C ^a,b   Gabrielsen, David ^a   Adams, Ted D ^a   Hunt, Steven C ^a   Hopkins, Paul N ^a   Cefalu, William T ^c   McClain, Donald A ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; FERRITIN; FERROPORTIN; IRON; TRANSCRIPTION FACTOR FKHR;

ADIPOCYTE; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DIET; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE TOLERANCE; HEMOCHROMATOSIS; HUMAN; INSULIN SENSITIVITY; IRON OVERLOAD; MALE; METABOLIC SYNDROME X; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHLEBOTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3T3-L1 CELLS; ADIPOCYTES; ADIPONECTIN; ADULT; ANIMALS; CATION TRANSPORT PROTEINS; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; FEMALE; FERRITINS; FORKHEAD TRANSCRIPTION FACTORS; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INSULIN RESISTANCE; IRON; IRON OVERLOAD; IRON, DIETARY; MALE; MEMBRANE PROTEINS; METABOLIC SYNDROME X; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; OBESITY; PHLEBOTOMY; RNA, MESSENGER;

EID: 84867167258     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI44421     Document Type: Article

References (83)

1. Fernandez-Real JM, Lopez-Bermejo A, Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes. 2002;51(8):2348-2354. (Pubitemid 34827381)
2. Ford ES, Cogswell ME. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care. 1999;22(12):1978-1983. (Pubitemid 30433975)
3. Forouhi NG, et al. Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia. 2007;50(5):949-956. (Pubitemid 46559245)
4. Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA. 2004; 291(6):711-717. (Pubitemid 38543791)
5. Afkhami-Ardekani M, Rashidi M. Iron status in women with and without gestational diabetes mellitus. J Diabetes Complications. 2009;23(3):194-198.
6. Sharifi F, Nasab NM, Zadeh HJ. Elevated serum ferritin concentrations in prediabetic subjects. Diab Vasc Dis Res. 2008;5(1):15-18. (Pubitemid 351507340)
7. Jehn M, Clark JM, Guallar E. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care. 2004;27(10):2422-2428. (Pubitemid 39281396)
8. Gillum RF. Association of serum ferritin and indices of body fat distribution and obesity in Mexican American men-the Third National Health and Nutrition Examination Survey. Int J Obes Relat Metab Disord. 2001;25(5):639-645. (Pubitemid 32417632)
9. Iwasaki T, et al. Serum ferritin is associated with visceral fat area and subcutaneous fat area. Diabetes Care. 2005;28(10):2486-2491. (Pubitemid 41384298)
10. Qi L, van Dam RM, Rexrode K, Hu FB. Heme iron from diet as a risk factor for coronary heart disease in women with type 2 diabetes. Diabetes Care. 2007; 30(1):101-106. (Pubitemid 46052506)
11. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448-454. (Pubitemid 29084777)
12. De Domenico I, McVey Ward D, Kaplan J. Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat Rev Mol Cell Biol. 2008;9(1):72-81.
13. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860-867. (Pubitemid 46024993)
14. Bofill C, et al. Response to repeated phlebotomies in patients with non-insulin-dependent diabetes mellitus. Metabolism. 1994;43(5):614-620. (Pubitemid 24145469)
15. Fernandez-Real JM, Penarroja G, Castro A, Garcia-Bragado F, Lopez-Bermejo A, Ricart W. Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity. Diabetes Care. 2002;25(12):2249-2255. (Pubitemid 41071036)
16. Facchini FS, Hua NW, Stoohs RA. Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Gastroenterology. 2002;122(4):931-939. (Pubitemid 34267276)
17. Fernandez-Real JM, Penarroja G, Castro A, Garcia-Bragado F, Hernandez-Aguado I, Ricart W. Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. Diabetes. 2002;51(4):1000-1004. (Pubitemid 34438342)
18. Jouihan HA CP. Iron-mediated inhibition of mitochondrial manganese uptake mediates mitochondrial dysfunction in a mouse model of hemochromatosis. Mol Med. 2008;14(3-4):98-108.
19. Abraham D, Rogers J, Gault P, Kushner J, McClain D. Increased insulin secretory capacity but decreased insulin sensitivity after correction of iron overload by phlebotomy in hereditary haemochromatosis. Diabetologia. 2006;49(11):2546-2551. (Pubitemid 44559521)
20. McClain D, et al. High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia. 2006;49(7):1661-1669. (Pubitemid 43848104)
21. -/-) mouse. Am J Physiol Endocrinol Metab. 2010;298(6):E1236-1243.
22. Fargnoli JL, Fung TT, Olenczuk DM, Chamberland JP, Hu FB, Mantzoros CS. Adherence to healthy eating patterns is associated with higher circulating total and high-molecular-weight adiponectin and lower resistin concentrations in women from the Nurses'Health Study. Am J Clin Nutr. 2008;88(5):1213-1224.
23. Mojiminiyi OA, Marouf R, Abdella NA. Body iron stores in relation to the metabolic syndrome, glycemic control and complications in female patients with type 2 diabetes. Nutr Metab Cardiovasc Dis. 2008; 18(8):559-566.
24. Ku B-J, Kim S-Y, Lee T-Y, Park K-S. Serum ferritin is inversely correlated with serum adiponectin level: population-based cross-sectional study. Dis Markers. 2009;27(6):303-310.
25. Weyer C, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86(5):1930-1935. (Pubitemid 32472900)
26. Kubota N, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002;277(29):25863-25866. (Pubitemid 34967064)
27. Stull AJ, Galgani JE, Johnson WD, Cefalu WT. The contribution of race and diabetes status to metabolic flexibility in humans. Metabolism. 2010; 59(9):1358-1364.
28. Fleming DJ, et al. Iron status of the free-living, elderly Framingham Heart Study cohort: an ironreplete population with a high prevalence of elevated iron stores. Am J Clin Nutr. 2001;73(3):638-646. (Pubitemid 32176517)
29. Nelson R, Chawla M, Connolly P, LaPorte J. Ferritin as an index of bone marrow iron stores. South Med J. 1978;71(12):1482-1484. (Pubitemid 9089231)
30. Cook JD, Lipschitz DA, Miles LEM, Finch CA. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr. 1974;27(7):681-687.
31. Arita Y, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257(1):79-83.
32. [No authors listed]. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-3421.
33. Green A, Basile R, Rumberger JM. Transferrin and iron induce insulin resistance of glucose transport in adipocytes. Metabolism. 2006;55(8):1042-1045. (Pubitemid 44026544)
34. Rumberger JM, Peters T Jr, Burrington C, Green A. Transferrin and iron contribute to the lipolytic effect of serum in isolated adipocytes. Diabetes. 2004;53(10):2535-2541. (Pubitemid 39299259)
35. Casey JL, et al. Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science. 1988;240(4854):924-928.
36. Qiao L, Shao J. SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex. J Biol Chem. 2006;281(52):39915-39924. (Pubitemid 46041795)
37. Liu M, Liu F. Transcriptional and post-translational regulation of adiponectin. Biochem J. 2010; 425(1):41-52.
38. van der Heide LP, Smidt MP. Regulation of FoxO activity by CBP/p300-mediated acetylation. Trends Biochem Sci. 2005;30(2):81-86.
39. Fan W, et al. FOXO1 transrepresses peroxisome proliferator-activated receptor gamma transactivation, coordinating an insulin-induced feed-forward response in adipocytes. J Biol Chem. 2009; 284(18):12188-12197.
40. Farahani P, et al. Obesity in BSB mice is correlated with expression of genes for iron homeostasis and leptin. Obes Res. 2004;12(2):191-204. (Pubitemid 41132542)
41. Bekri S, et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology. 2006;131(3):788-796.
42. Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem. 2000;275(26):19906-19912. (Pubitemid 30441595)
43. Donovan A, et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 2000;403(6771):776-781.
44. Nemeth E, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090-2093. (Pubitemid 40007660)
45. Donovan A, et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 2005;1(3):191-200. (Pubitemid 43960600)
46. Huang J, et al. Increased glucose disposal and AMP-dependent kinase signaling in a mouse model of hemochromatosis. J Biol Chem. 2007; 282(52):37501-37507.
47. Ross CE, Muir WA, Alan BP, Graham RC, Kellermeyer RW. Hemochromatosis. Pathophysiologic and genetic considerations. Am J Clin Pathol. 1975; 63(2):179-191.
48. Cairo G, Recalcati S, Montosi G, Castrusini E, Conte D, Pietrangelo A. Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis. Blood. 1997; 89(7):2546-2553. (Pubitemid 27143304)
49. Furukawa S, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752-1761. (Pubitemid 40385531)
50. Nawrocki AR, et al. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem. 2006; 281(5):2654-2660. (Pubitemid 43845727)
51. Bergman RN, Finegood DT, Kahn SE. The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes. Eur J Clin Invest. 2002;3(1):35-45. (Pubitemid 41704998)
52. Tanner LI, Lienhard GE. Insulin elicits a redistribution of transferrin receptors in 3T3-L1 adipocytes through an increase in the rate constant for receptor externalization. J Biol Chem. 1987;262(19):8975-8980. (Pubitemid 17095759)
53. Davis RJ, Corvera S, Czech MP. Insulin stimulates cellular iron uptake and causes the redistribution of intracellular transferrin receptors to the plasma membrane. J Biol Chem. 1986;261(19):8708-8711. (Pubitemid 17205066)
54. Yamagishi H, Okazaki H, Shimizu M, Izawa T, Komabayashi T. Relationships among serum triacylglycerol, fat pad weight, and lipolysis in iron-deficient rats. J Nutr Biochem. 2000;11(9):455-460.
55. Haurie V, Boucherie H, Sagliocco F. The Snf1 protein kinase controls the induction of genes of the iron uptake pathway at the diauxic shift in Saccharomyces cerevisiae. J Biol Chem. 2003;278(46):45391-45396. (Pubitemid 37432676)
56. Shakoury-Elizeh M, et al. Metabolic response to iron deficiency in Saccharomyces cerevisiae. J Biol Chem. 2010;285(19):14823-14833.
57. Festa M, Ricciardelli G, Mele G, Pietropaolo C, Ruffo A, Colonna A. Overexpression of H ferritin and up-regulation of iron regulatory protein genes during differentiation of 3T3-L1 pre-adipocytes. J Biol Chem. 2000;275(47):36708-36712. (Pubitemid 32002076)
58. Lee P, Peng H, Gelbart T, Wang L, Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci U S A. 2005; 102(6):1906-1910. (Pubitemid 40261985)
59. Huang J, et al. Iron overload and diabetes risk: a shift from glucose to fatty acid oxidation and increased hepatic glucose production in a mouse model of hereditary hemochromatosis. Diabetes. 2011; 60(1):80-87.
60. Yamauchi T, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7(8):941-946. (Pubitemid 32756432)
61. Qiang L, Banks AS, Accili D. Uncoupling of acetylation from phosphorylation regulates FoxO1 function independent of its subcellular localization. J Biol Chem. 2010;285(35):27396-27401.
62. Subauste AR, Burant CF. Role of FoxO1 in FFAinduced oxidative stress in adipocytes. Am J Physiol Endocrinol Metab. 2007;293(1):E159-E164. (Pubitemid 47105929)
63. Nakae J, Kitamura T, Kitamura Y, Biggs WH 3rd, Arden KC, Accili D. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell. 2003;4(1):119-129. (Pubitemid 36105338)
64. Nakae J, et al. Forkhead transcription factor FoxO1 in adipose tissue regulates energy storage and expenditure. Diabetes. 2008;57(3):563-576.
65. Gross DN, van den Heuvel AP, Birnbaum MJ. The role of FoxO in the regulation of metabolism. Oncogene. 2008;27(16):2320-2336. (Pubitemid 351501783)
66. Hatunic M, Finucane FM, Brennan AM, Norris S, Pacini G, Nolan JJ. Effect of iron overload on glucose metabolism in patients with hereditary hemochromatosis. Metabolism. 2010;59(3):380-384.
67. Cooksey RC, et al. Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology. 2004;145(11):5305-5312. (Pubitemid 39551152)
68. Brink B, Disler P, Lynch S, Jacobs P, Charlton R, Bothwell T. Patterns of iron storage in dietary iron overload and idiopathic hemochromatosis. J Lab Clin Med. 1976;88(5):725-731.
69. Szmuilowicz ED, Stuenkel CA, Seely EW. Influence of menopause on diabetes and diabetes risk. Nat Rev Endocrinol. 2009;5(10):553-558.
70. Walters GO, Miller FM, Worwood M. Serum ferritin concentration and iron stores in normal subjects. J Clin Pathol. 1973;26(10):770-772.
71. Mangiagli A, Italia S, Campisi S. Glucose tolerance and beta-cell secretion in patients with thalassaemia major. J Pediatr Endocrinol Metab. 1998;11:985-986.
72. Cheng K, et al. Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets. J Clin Invest. 2010;120(6):2171-2183.
73. Fernandez-Real JM, Lopez-Bermejo A, Ricart W. Iron stores, blood donation, and insulin sensitivity and secretion. Clin Chem. 2005;51(7):1201- 1205. (Pubitemid 43079398)
74. McClung J, Karl J. Iron deficiency and obesity: the contribution of inflammation and diminished iron absorption. Nutr Rev. 2009;67(2):100-104.
75. Semenza GL. Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis. Blood. 2009;114(10):2015-2019.
76. Zhou XY, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci U S A. 1998;95(5):2492-2497. (Pubitemid 28145969)
77. Adams TD, et al. Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obese. Obesity (Silver Spring). 2010; 18(1):121-130.
78. Saad MF, et al. Method of insulin administration has no effect on insulin sensitivity estimates from the insulin-modified minimal model protocol. Diabetes. 1997;46(12):2044-2048. (Pubitemid 27512094)
79. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part. 1998;15(7):539-553.
80. Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN. MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther. 2003;5(6):1003-1015. (Pubitemid 38009940)
81. Chen Z, Torrens JI, Anand A, Spiegelman BM, Friedman JM. Krox20 stimulates adipogenesis via C/EBPbeta-dependent and -independent mechanisms. Cell Metab. 2005;1(2):93-106. (Pubitemid 43960592)
82. Chakrabarti P, Kandror KV. FoxO1 controls insulin-dependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes. J Biol Chem. 2009;284(20):13296-13300.
83. Seo JB, et al. Adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element-binding protein 1c regulates mouse adiponectin expression. J Biol Chem. 2004;279(21):22108-22117. (Pubitemid 38679403)